Skip to content
Home/Companies/TMT/Antelliq

Antelliq

TMT·France·Exited 2019·Held 6yr
Entry
2013
Hold
6yr
Exit
2019

Who owns Antelliq?

Antelliq was owned by BC Partners through BC European Capital IX (2012 vintage) from 2013 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

BC Partners
Investor
BC Partners
BC European Capital IX · 2012 · Buyout

Key facts

HQFrance
SectorTMT
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from BC European Capital IX

Other portfolio companies in the same fund.

Cigierre
Active
HospitalityItaly· 2015
Pharmathen
Exited 2021
PharmaGreece· 2015
to
Acuris
Exited 2019
Business ServicesUK· 2014
to
CarTrawler
Active
SaaSIreland· 2014
Springer Nature
Springer Nature
Exited 2024
TMTGermany· 2013
Springer SBM
Active
TMTGermany· 2013

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Antelliq

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Antelliq?

1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Antelliq.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue